The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2013

Filed:

Nov. 09, 2006
Applicants:

Weiqun Yang, Cupertino, CA (US);

Malin Ohlander, Stockholm, SE;

Louis Wong, Sunnyvale, CA (US);

Nils Holmstrom, Jarfalla, SE;

Cem Shaquer, San Jose, CA (US);

Euljoon Park, Valencia, CA (US);

Dorin Panescu, San Jose, CA (US);

Shahrooz Shahparnia, Campbell, CA (US);

Andre Walker, Monte Sereno, CA (US);

Ajit Pillai, Sunnyvale, CA (US);

Mihir Naware, San Jose, CA (US);

Inventors:

Weiqun Yang, Cupertino, CA (US);

Malin Ohlander, Stockholm, SE;

Louis Wong, Sunnyvale, CA (US);

Nils Holmstrom, Jarfalla, SE;

Cem Shaquer, San Jose, CA (US);

Euljoon Park, Valencia, CA (US);

Dorin Panescu, San Jose, CA (US);

Shahrooz Shahparnia, Campbell, CA (US);

Andre Walker, Monte Sereno, CA (US);

Ajit Pillai, Sunnyvale, CA (US);

Mihir Naware, San Jose, CA (US);

Assignee:

Pacesetter, Inc., Sunnyvale, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/05 (2006.01); A61N 1/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

An implantable device monitors and treats heart failure, pulmonary edema, and hemodynamic conditions and in some cases applies therapy. In one implementation, the implantable device applies a high-frequency multi-phasic pulse waveform over multiple-vectors through tissue. The waveform has a duration less than the charging time constant of electrode-electrolyte interfaces in vivo to reduce intrusiveness while increasing sensitivity and specificity for trending parameters. The waveform can be multiplexed over multiple vectors and the results cross-correlated or subjected to probabilistic analysis or thresholding schemata to stage heart failure or pulmonary edema. In one implementation, a fractionation morphology of a sensed impedance waveform is used to trend intracardiac pressure to stage heart failure and to regulate cardiac resynchronization therapy. The waveform also provides unintrusive electrode integrity checks and 3-D impedancegrams.


Find Patent Forward Citations

Loading…